GNAS mutations identify a set of right-sided, RAS mutant, villous colon cancers

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Fecteau, Ryan E ^a   Lutterbaugh, James ^b   Markowitz, Sanford D ^a,b   Willis, Joseph ^a,b   Guda, Kishore ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; B RAF KINASE; CYSTEINE; HISTIDINE; K RAS PROTEIN;

ARTICLE; CANCER STAGING; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL TUMOR; FEMALE; GENE FREQUENCY; GNAS GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; ONCOGENE RAS; POPULATION RESEARCH; PROTEIN LOCALIZATION; PYROSEQUENCING; TUMOR GENE;

COLONIC NEOPLASMS; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MALE; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS;

EID: 84900444219     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087966     Document Type: Article

References (20)

1. Markowitz SD, Bertagnolli MM (2009) Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 361: 2449-2460. doi:10.1056/NEJMra0804588.
2. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274. doi:10.1126/science.1133427. (Pubitemid 44571966)
3. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113. doi:10.1126/science.1145720. (Pubitemid 350134889)
4. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, et al. (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692-696. doi:10.1038/340692a0. (Pubitemid 19214389)
5. Kalfa N, Lumbroso S, Boulle N, Guiter J, Soustelle L, et al. (2006) Activating mutations of Gsalpha in kidney cancer. J Urol 176: 891-895. doi:10.1016/j.juro.2006.04.023. (Pubitemid 44142552)
6. Fragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, et al. (1998) Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocrinol Metab 83: 2074-2078. (Pubitemid 28496339)
7. Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimeno C, Barreiro-Morandeira F, et al. (2008) Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Eur J Endocrinol Eur Fed Endocr Soc 159: 623-631. doi:10.1530/EJE-08-0313.
8. Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, et al. (2011) Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 3: 92ra66. doi:10.1126/scitranslmed.3002543.
9. Lyons J, Landis CA, Harsh G, Vallar L, Grünewald K, et al. (1990) Two G protein oncogenes in human endocrine tumors. Science 249: 655-659. (Pubitemid 20259082)
10. Weinstein LS, Liu J, Sakamoto A, Xie T, Chen M (2004) Minireview: GNAS: normal and abnormal functions. Endocrinology 145: 5459-5464. doi:10.1210/en.2004-0865. (Pubitemid 39564584)
11. Wilson CH, McIntyre RE, Arends MJ, Adams DJ (2010) The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways. Oncogene 29: 4567-4575. doi:10.1038/onc.2010.202.
12. Idziaszczyk S, Wilson CH, Smith CG, Adams DJ, Cheadle JP (2010) Analysis of the frequency of GNAS codon 201 mutations in advanced colorectal cancer. Cancer Genet Cytogenet 202: 67-69. doi:10.1016/j.cancergencyto.2010.04.023.
13. Yamada M, Sekine S, Ogawa R, Taniguchi H, Kushima R, et al. (2012) Frequent activating GNAS mutations in villous adenoma of the colorectum. J Pathol Available: http://www.ncbi.nlm.nih.gov/pubmed/22374786. Accessed 2013 June 27.
14. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159. doi:10.1006/abio.1987.9999. (Pubitemid 17064313)
15. Grady WM, Rajput A, Myeroff L, Liu DF, Kwon K, et al. (1998) Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res 58: 3101-3104. (Pubitemid 28335093)
16. Guda K, Natale L, Lutterbaugh J, Wiesner GL, Lewis S, et al. (2009) Infrequent Detection of Germline Allele-Specific Expression of TGFBR1 in Lymphoblasts and Tissues of Colon Cancer Patients. Cancer Res 69: 4959-4961. doi:10.1158/0008-5472.CAN-09-0225.
17. O'Brien MJ, Winawer SJ, Zauber AG, Gottlieb LS, Sternberg SS, et al. (1990) The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 98: 371-379. (Pubitemid 20037919)
18. Loy TS, Kaplan PA (2004) Villous adenocarcinoma of the colon and rectum: a clinicopathologic study of 36 cases. Am J Surg Pathol 28: 1460-1465. (Pubitemid 39425512)
19. Rubio CA, Yanagisawa A, Kato Y (1998) Histologic phenotypes of colonic carcinoma in Sweden and in Japan. Anticancer Res 18: 2649-2655. (Pubitemid 28386562)
20. Vaughn CP, ZoBell SD, Furtado LV, Baker CL, Samowitz WS (2011) Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer. Genes Chromosomes Cancer 50: 307-312. doi:10.1002/gcc.20854.